Nicholas A.J. Botwood, Head of R&D, CMO: Syndax Pharmaceuticals SNDX Planned sale · Filed 06/12

Trade details

Type: Planned sale notice
Stock: Syndax Pharmaceuticals SNDX
Person: Nicholas A.J. BotwoodHead of R&D, CMO
Planned sale date: 26/06/12
Filed: 26/06/12

More to sell after $609.4K in 3 months

Syndax Pharmaceuticals trades, last 26 weeks

What else happened in Syndax Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 05/13~07/12

Nicholas A.J. Botwood's recent trades

Nicholas A.J. BotwoodHead of R&D, CMO
Sell10b5-1 planSyndax Pharmaceuticals
Sell10b5-1 plan
Syndax Pharmaceuticals
SNDX
$617K
34,280 sh
$617K
Filed 06/12
Traded 06/11
Nicholas A.J. BotwoodHead of R&D, CMO
Sell10b5-1 planSyndax Pharmaceuticals
Sell10b5-1 plan
Syndax Pharmaceuticals
SNDX
$566.6K
31,235 sh
$566.6K
Filed 06/12
Traded 06/12
Nicholas A.J. BotwoodHead of R&D, CMO
Planned sale10b5-1 planSyndax Pharmaceuticals
Planned sale10b5-1 plan
Syndax Pharmaceuticals
SNDX
$609.4K
34,280 sh
$609.4K
Filed 06/11
Traded 06/11
Nicholas A.J. BotwoodHead of R&D, CMO
BuySyndax Pharmaceuticals
Buy
Syndax Pharmaceuticals
SNDX
$105.9K
11,765 sh
$105.9K
Filed 25/05/19
Traded 25/05/16